Skip to main content
. 2023 Oct 14;16:250–262. doi: 10.1016/j.xjon.2023.10.010

Table E1.

Missingness for Table 1

Variable Overall, n (%) No TV operation, n (%) Concomitant TV operation, n (%)
Age 0 (0.0) 0 (0.0) 0 (0.0)
Female sex 0 (0.0) 0 (0.0) 0 (0.0)
BMI (kg/m2) 0 (0.0) 0 (0.0) 0 (0.0)
Race 0 (0.0) 0 (0.0) 0 (0.0)
Mitral etiology 0 (0.0) 0 (0.0) 0 (0.0)
Mitral regurgitation 0 (0.0) 0 (0.0) 0 (0.0)
Mitral stenosis 0 (0.0) 0 (0.0) 0 (0.0)
Tricuspid etiology 0 (0.0) 0 (0.0) 0 (0.0)
LVEF (%) 0 (0.0) 0 (0.0) 0 (0.0)
PASP (mm Hg) 36 (17.1) 25 (17.5) 11 (16.4)
NYHA class 3 or 4 2 (1.0) 2 (1.4) 0 (0.0)
Comorbidities
 Hypertension 0 (0.0) 0 (0.0) 0 (0.0)
 Atrial fibrillation 0 (0.0) 0 (0.0) 0 (0.0)
 Chronic lung disease 1 (0.5) 1 (0.7) 0 (0.0)
 Diabetes 0 (0.0) 0 (0.0) 0 (0.0)
 Dialysis 0 (0.0) 0 (0.0) 0 (0.0)
Prior cardiac intervention 0 (0.0) 0 (0.0) 0 (0.0)
 Prior mitral surgery 0 (0.0) 0 (0.0) 0 (0.0)
 Prior TV surgery 0 (0.0) 0 (0.0) 0 (0.0)
 Prior CABG 0 (0.0) 0 (0.0) 0 (0.0)
 Prior PCI 0 (0.0) 0 (0.0) 0 (0.0)
 Prior PPM 0 (0.0) 0 (0.0) 0 (0.0)
Laboratory values
 Creatinine (mg/dL) 0 (0.0) 0 (0.0) 0 (0.0)
 WBC count (109/L) 1 (0.5) 1 (0.7) 0 (0.0)
 Hematocrit (%) 0 (0.0) 0 (0.0) 0 (0.0)

TV, Tricuspid valve; BMI, body mass index; LVEF, left ventricular ejection fraction; PASP, pulmonary artery systolic pressure; NYHA, New York Heart Association; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; PPM, permanent pacemaker placement; WBC, white blood cell.